课题基金 / 基金详情

RADIOPROTECTANT COPPER COMPLEX, CU(11)(3,5-DIPS)2

RADIOPROTECTANT COPPER COMPLEX, CU(11)(3,5-DIPS)2
辐射防护铜络合物,CU(11)(3,5-DIPS)2
批准号:
3180235
负责人:
John Robert Joseph Sorenson
金额:
$9.92万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-30 至 1988-08-31

项目摘要

项目成果

John Robert Joseph Sorenson的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Long term objectives are to evaluate Bis 3,5-diisopropylsaliclatocopper (II) Cu(II)(3,5-dips)2 treatment regimens for radioprotection of cells grown in culture and mice irradiated with clinically relevant doses of X- and gamma-radiation (40-170 rads/minute to deliver 800 to 1000 rads), and evaluate effects of radiation and treatment (0, 60, 80, or 100 mg/kg) on essential metalloelement metabolism and immunocompetency of mice. Specific aims of this proposal are to synthesize sufficient quantities of Cu(II) (3,5-dips)2 to enable studies of its radioprotectant activity. Radioprotectant activity will be determined by measuring survival of irradiated cultured cells and whole-body irradiated mice. Survival and treatment regimen will be correlated for irradiated cells grown in culture. Altered essential metalloelement metabolism and immunocompetency will be determined for irradiated and treated mice. Survival, alteration of plasma, liver, spleen, intestine, brain, and bone marrow copper content as well as immunocompetency will be correlated for irradiated and treated mice. Routine synthetic procedures will be used to synthesize Cu(II)(3,5-dips)2. Atomic absorption spectrophotometric methods will be used to determine tissue copper content. Colony formation, as measured with Puck-Marcus single cell techniques, will be used to determine irradiated-cell survival. Survival will also be used to measure the in vivo radioprotectant activity. Immunocompetency will be determined by evaluating the abilities of different lymphocyte subclasses to repopulate hosts with determinations of spleen cell markers, mitogen responsiveness, and bone marrow colony forming units. Antibody responsiveness will be measured using the Jerne plaque-forming assay and determinations of cell-mediated immunity will be measured using oxazolone hypersensitivity and mixed lymphocyte reactivity. Appropriate statistical programs will be used to evaluate significance of differences found in these studies.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
Combination therapy with CuDIPS, Tween 80 and cyclophosphamide: effects on survival and tumor incidence in SJL/J mice.
CuDIPS、Tween 80 和环磷酰胺联合治疗:对 SJL/J 小鼠生存和肿瘤发生率的影响。
DOI: --
发表时间: 1990
期刊: In vivo (Athens, Greece)
影响因子: --
作者: [CrispensJr,CG, Sorenson,JR]
通讯作者: Sorenson,JR
Pharmacokinetic distribution of 67Cu(II)2[3,5-diisopropyl(carboxy-14C)salicylate]4 among murine tissues.
67Cu(II)2[3,5-二异丙基(羧基-14C)水杨酸酯]4 在小鼠组织中的药代动力学分布。
DOI: 10.2174/0929867043363992
发表时间: 2004
期刊: Current medicinal chemistry
影响因子: 4.1
作者: [Blincoe,Clifton, Chidambaram,Mani, Salari,Hamid, Bond,KyleB, Evans,DorisT, Gray-Kaufman,RhondaA, Griffey,HalBrent, Tranby,SandraGilbreth, Garner-Johnson,Buffy, Lee,Tina, Sorenson,JohnRJ]
通讯作者: Sorenson,JohnRJ
Copper complexes stimulate hemopoiesis and lymphopoiesis.
铜络合物刺激造血和淋巴细胞生成。
DOI: 10.1007/978-1-4613-0537-8_18
发表时间: 1989
期刊: Advances in experimental medicine and biology
影响因子: --
作者: [Soderberg,LS, Barnett,JB, Sorenson,JR]
通讯作者: Sorenson,JR
Treatment of reticulum cell sarcoma in SJL/J mice with Tween 80.
使用 Tween 80 治疗 SJL/J 小鼠网状细胞肉瘤。
DOI: --
发表时间: 1988
期刊: Anticancer research
影响因子: 2
作者: [CrispensJr,CG, Sorenson,JR]
通讯作者: Sorenson,JR
11
    RADIOPROTECTANT COPPER COMPLEX--CU-LL-3,5-DIPS-2
    • 批准号:
      3180234
    • 项目类别:
    • 资助金额:
      $9.65万
    • 财政年份:
      1986
    • 负责人:
      John Robert Joseph Sorenson
    • 依托单位: